Finn Dixon & Herling served as legal counsel to Oak HC/FT, a venture and capital growth equity firm specializing in investments in fintech and healthcare, in raising $60 Million Series B for Akido to expand the reach of ScopeAI, a system that increases clinical capacity and improves healthcare access. Oak HC/FT led the round with participation from Greco, SNR, and existing investors Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Research), and the Comprehensive Blood & Cancer Center.
The completed deal was announced by Akido in a May 15 press release.
Using partnership as a foundation, Oak HC/FT guides companies and founders at every stage, from seed to growth, to create businesses that make a measurable and lasting impact. Founded in 2014, Oak HC/FT has invested in over 85 portfolio companies and has over $5.3 billion in assets under management.
The FDH team responsible for this deal includes corporate partner Chris Mozingo and corporate associates James Redman and Kendall Kirk.